Drug comparisons
Dapagliflozin vs Pioglitazone
Dapagliflozin vs Pioglitazone: Farxiga (SGLT2) vs Actos (TZD) for diabetes. Heart/kidney protection vs insulin resistance treatment and HF risk.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting add-on oral therapy for type 2 diabetes patients with or at risk for heart failure or chronic kidney disease.
Bottom line
Dapagliflozin typically provides broader cardioprotective and renal benefits compared to pioglitazone, which has notable heart failure risks.
All medication comparisons